+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 21Years +
All Genders
ID06087029

Improving Outcomes in Vascular Disease Comparing TEVAR Plus Medical Therapy Versus Medical Therapy Alone for Uncomplicated Type B Aortic Dissection

Led by Duke University · Updated on 2026-10-14

1100

Participants Needed

66

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare two treatment strategies for patients with uncomplicated type B aortic dissection, a serious condition affecting the aorta. The study evaluates whether an initial invasive approach using thoracic endovascular aortic repair TEVAR plus medical therapy reduces death or major aortic problems better than a conservative strategy of medical therapy with monitoring. The trial is a prospective, randomized clinical trial enrolling adults within 48 hours to 6 weeks after their initial hospital admission for this condition. Participants are randomly assigned to one of two groups one receives the TEVAR procedure using a customized stent-graft implanted with imaging guidance, alongside medical therapy the other group undergoes medical therapy alone with recommended blood pressure and cardiovascular risk management. The study allows aortic interventions only as specified by the protocol, while other care is managed by usual clinical teams. Follow-up includes centralized record review and remote blood pressure monitoring, with median follow-up planned for about 4 years. During the study, participants will be monitored through medical records and phone contacts, including assessments of quality of life and cardiovascular events. Researchers will measure outcomes such as all-cause death, major aortic complications, and hospitalizations over the follow-up period. Safety, quality of care, and cardiovascular events, including strokes and other complications, will be closely tracked. Participation may last several years with ongoing observation to evaluate long-term effects of the treatment strategies.

CONDITIONS

Brief Title

IMPRoving Outcomes in Vascular DisEase - Aortic Dissection

Research Team

M

Megan Roebuck, M.S.

K

Kady-Ann Steen-Burrell, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here